CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression

被引:202
|
作者
Carreno, BM
Bennett, F
Chau, TA
Ling, V
Luxenberg, D
Jussif, J
Baroja, ML
Madrenas, J
机构
[1] Univ Western Ontario, John P Robarts Res Inst, London, ON N6A 5K8, Canada
[2] Genet Inst Inc, Cambridge, MA 02140 USA
来源
JOURNAL OF IMMUNOLOGY | 2000年 / 165卷 / 03期
关键词
D O I
10.4049/jimmunol.165.3.1352
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CTLA-4 (CD152) engagement results in down-regulation of T cell activation. Two mechanisms have been postulated to explain CTLA-4 inhibition of T cell activation: negative signaling and competitive antagonism of CD28:B7-mediated costimulation, We assessed the contributions of these two mechanisms using a panel of T cell lines expressing human CTLA-4 with mutations in the cytoplasmic region. Under conditions of B7-independent costimulation, inhibition of IL-2 production following CTLA-4 engagement required the CTLA-4 cytoplasmic region. In contrast, under B7-dependent costimulation, inhibition of IL-2 production by CTLA-4 engagement was directly proportional to CTLA-4 cell surface levels and did not require its cytoplasmic region. Thus, CTLA-4 down-regulates T cell activation by two different mechanisms-delivery of a negative signal or B7 sequestration-that are operational depending on the levels of CTLA-4 surface expression. These two mechanisms may have distinct functional outcomes: rapid inhibition of T cell activation or induction of T cell anergy.
引用
收藏
页码:1352 / 1356
页数:5
相关论文
共 50 条
  • [11] CTLA-4 (CD152) expression in T cells during the acute stage of Kawasaki disease
    Matsubara, T
    Fujiwara, M
    Koga, M
    Ichiyama, T
    Furukawa, S
    PEDIATRIC RESEARCH, 2003, 53 (01) : 161 - 161
  • [12] Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis
    Steiner, K
    Moosig, F
    Csernok, E
    Selleng, K
    Gross, WL
    Fleischer, B
    Bröker, BM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (01): : 143 - 150
  • [13] Blockage of the T-cell co-inhibitory surface molecule Ctla-4 (Cd152) in necrotising pancreatitis increases mortality
    Mayerle, Julia
    Demmer, Annegret
    Sunder, Cathleen
    Kalkowski, Janine
    Weiss, Frank U.
    Busse, Mandy
    Sendler, Matthias
    Broker, Barbara M.
    Lerch, Markus M.
    GASTROENTEROLOGY, 2007, 132 (04) : A251 - A251
  • [14] Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia
    M Motta
    L Rassenti
    B J Shelvin
    S Lerner
    T J Kipps
    M J Keating
    W G Wierda
    Leukemia, 2005, 19 : 1788 - 1793
  • [15] Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia
    Motta, M
    Rassenti, L
    Shelvin, BJ
    Lerner, S
    Kipps, TJ
    Keating, MJ
    Wierda, WG
    LEUKEMIA, 2005, 19 (10) : 1788 - 1793
  • [16] C-domain of CD80 is important in CTLA-4 (CD152) mediated T cell down-regulation
    Holterman, M
    Vasu, C
    Wang, A
    Rao, S
    Kaithamana, S
    Prabhakar, BS
    FASEB JOURNAL, 2002, 16 (04): : A712 - A712
  • [17] Regulation of CTLA-4 expression during T cell activation
    Perkins, D
    Wang, ZM
    Donovan, C
    He, HZ
    Mark, D
    Guan, GM
    Wang, YS
    Walunas, T
    Bluestone, J
    Listman, J
    Finn, PW
    JOURNAL OF IMMUNOLOGY, 1996, 156 (11): : 4154 - 4159
  • [18] Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia
    Frydecka, I
    Kosmaczewska, A
    Bocko, D
    Ciszak, L
    Wolowiec, D
    Kuliczkowski, K
    Kochanowska, I
    BRITISH JOURNAL OF CANCER, 2004, 90 (10) : 2042 - 2048
  • [19] Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia
    I Frydecka
    A Kosmaczewska
    D Bocko
    L Ciszak
    D Wolowiec
    K Kuliczkowski
    I Kochanowska
    British Journal of Cancer, 2004, 90 : 2042 - 2048
  • [20] CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
    Chemnitz, JM
    Riley, JL
    Frauwirth, KA
    Braunstein, I
    Kobayashi, SV
    Linsley, PS
    Thompson, CB
    Parry, RV
    BLOOD, 2004, 104 (11) : 726A - 726A